Optimism / Turkey Lira
37.86
06-February-25 15:23:03
realtime
Instruments
-1.37
-3.49%
Today's range
37.32 - 40.73
ISIN
FXOPTRY
Source
BINCE
-
Fed's Goolsbee: First effects of tariffs may be less imporant than impacts on expectations
06 Feb 2025 14:48:22 By Buzz FX
-
Bessent Signals Trump White House Won't Pressure Fed on Rates
06 Feb 2025 14:41:19 By Buzz FX
-
Donald Trump doubles down on Gaza takeover; BoE cuts rates
06 Feb 2025 14:40:21 By Buzz FX
-
Do investment tax breaks work? A new study finds the evidence is 'mixed at best'
06 Feb 2025 14:31:21 By Buzz FX
-
Rezolve AI (NASDAQ:RZLV) Trading 12.6% Higher - Still a Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
NIO (NYSE:NIO) Shares Up 1.1% - Still a Buy? | MarketBeat
06 Feb 2025 14:31:10 By Buzz FX
-
MARA (NASDAQ:MARA) Trading 0.4% Higher - Still a Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
Roku (NASDAQ:ROKU) Trading Up 0.3% - Should You Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
Rivian Automotive (NASDAQ:RIVN) Trading Up 1.2% - Time to Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
Schlumberger (NYSE:SLB) Stock Price Down 1.8% - Time to Sell?
06 Feb 2025 14:31:10 By Buzz FX
-
Serve Robotics (NASDAQ:SERV) Trading Up 2.6% - Time to Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
Aramark (NYSE:ARMK) Trading Up 0.6% - Still a Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
Intuitive Surgical (NASDAQ:ISRG) Trading Down 0.2% - Time to Sell?
06 Feb 2025 14:31:10 By Buzz FX
-
Lucid Group (NASDAQ:LCID) Shares Up 0.9% - Still a Buy?
06 Feb 2025 14:31:10 By Buzz FX
-
JPMorgan Chase & Co. (NYSE:JPM) Trading Up 1.3% - What's Next?
06 Feb 2025 14:31:10 By Buzz FX
-
Matthews International (NASDAQ:MATW) Sees Unusually-High Trading Volume - Time to Buy?
06 Feb 2025 14:26:10 By Buzz FX
-
JPMorgan Chase & Co. Lowers Uber Technologies (NYSE:UBER) Price Target to $90.00
06 Feb 2025 14:26:10 By Buzz FX
-
Mondelez International (NASDAQ:MDLZ) Price Target Lowered to $60.00 at The Goldman Sachs Group
06 Feb 2025 14:26:10 By Buzz FX
-
ARM (NASDAQ:ARM) Earns "Hold" Rating from Benchmark
06 Feb 2025 14:26:10 By Buzz FX
-
Needham & Company LLC Reaffirms "Buy" Rating for Recursion Pharmaceuticals (NASDAQ:RXRX)
06 Feb 2025 14:26:10 By Buzz FX